Malawi study tracks why women stop HIV prevention
NCT ID NCT07579754
First seen Jun 27, 2026 · Last updated Jul 16, 2026 · Updated 4 times
Summary
This study looks at how women in Blantyre, Malawi choose and use HIV prevention pills or injections. Researchers will follow 384 women to see why some stop taking PrEP and how tracing them can help re-engage them in care. The goal is to improve HIV prevention services for women at risk.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for LONG-ACTING INJECTABLE CABOTEGRAVIR FOR PREP are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Johns Hopkins Research Project Malawi
RECRUITINGBlantyre, Malawi
Contact
Contact Phone: •••-•••-•••• Email: •••••@•••••
More trials for these conditions
Other studies related to the condition(s) this trial covers.